Octavio Espinoza, Chief Financial Officer at LIGAND PHARMACEUTICALS INC (LGND), sold 4,208 shares at $116.37 ($490K) on 2024-12-23, disclosed to the SEC on 2024-12-26.
Open-market sale of $490k LGND by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $116.37 | 2,104 | $245K | 50.0% |
| 2 | $116.37 | 2,104 | $245K | 50.0% |
| Total | $116.37 avg | 4,208 | $490K | 100% |
| Filing → |
| LGND | SELL | 2026-03-06 | $5.5M | — | Filing → |
| LGND | SELL | 2025-12-16 | $679K | — | Filing → |
| LGND | BUY | 2025-05-13 | $156K | — | Filing → |